New York Life Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | $15K | Sell |
214
-2,441
| -92% | -$171K | 0.73% | 25 |
|
2016
Q4 | $190K | Buy |
2,655
+110
| +4% | +$7.87K | 0.9% | 27 |
|
2016
Q3 | $201K | Buy |
2,545
+181
| +8% | +$14.3K | 0.99% | 25 |
|
2016
Q2 | $197K | Sell |
2,364
-428
| -15% | -$35.7K | 0.96% | 27 |
|
2016
Q1 | $256K | Sell |
2,792
-101
| -3% | -$9.26K | 1.11% | 23 |
|
2015
Q4 | $293K | Buy |
2,893
+21
| +0.7% | +$2.13K | 1.26% | 19 |
|
2015
Q3 | $282K | Sell |
2,872
-35
| -1% | -$3.44K | 1.25% | 15 |
|
2015
Q2 | $340K | Sell |
2,907
-236
| -8% | -$27.6K | 1.41% | 10 |
|
2015
Q1 | $308K | Sell |
3,143
-4
| -0.1% | -$392 | 1.23% | 12 |
|
2014
Q4 | $297K | Buy |
3,147
+1,074
| +52% | +$101K | 1.17% | 20 |
|
2014
Q3 | $221K | Buy |
2,073
+1,284
| +163% | +$137K | 0.91% | 25 |
|
2014
Q2 | $65K | Buy |
789
+29
| +4% | +$2.39K | 0.27% | 134 |
|
2014
Q1 | $54K | Buy |
760
+39
| +5% | +$2.77K | 0.24% | 135 |
|
2013
Q4 | $54K | Sell |
721
-2,251
| -76% | -$169K | 0.25% | 137 |
|
2013
Q3 | $187K | Sell |
2,972
-665
| -18% | -$41.8K | 0.94% | 26 |
|
2013
Q2 | $186K | Buy |
+3,637
| New | +$186K | 0.86% | 29 |
|